Preoperative Hepatic Arterial Infusion Chemotherapy
|ClinicalTrials.gov Identifier: NCT00522509|
Recruitment Status : Unknown
Verified May 2007 by IRCCS San Raffaele.
Recruitment status was: Active, not recruiting
First Posted : August 29, 2007
Last Update Posted : August 29, 2007
|Condition or disease||Intervention/treatment|
|Colorectal Liver Metastases||Drug: Floxuridine FUDR|
Between 1995 and 2004, 239 patients with isolated colorectal liver metastases received HAI chemotherapy with neoadjuvant intent. Fifty of these patients underwent subsequent curative liver resection (HAI group).
Postoperative morbidity, liver function tests, and long term outcomes were evaluated. Adverse events related to HAI chemotherapy were also evaluated.
|Study Type :||Observational|
|Observational Model:||Defined Population|
|Observational Model:||Natural History|
|Official Title:||Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases|
|Study Start Date :||December 1995|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00522509
|Department of Surgery - Liver Unit, Scientific Institute San Raffaele,|
|Milan, Italy, 20132|
|Principal Investigator:||Luca Aldrighetti, M.D, PhD||Department of Surgery - Liver Unit, Scientific Institute San Raffaele,|